BioCorRx (BICX) Convertible Debt (2012 - 2019)

BioCorRx's Convertible Debt history runs 7 years deep, the most recent figure standing at $4.2 million for Q4 2019.

• In Q4 2019, Convertible Debt changed N/A year-over-year to $4.2 million; the TTM figure through Dec 2019 stood at $4.2 million (changed N/A YoY), while the FY2019 annual figure was $4.2 million, changed N/A from the prior year.
• Convertible Debt came in at $4.2 million for Q4 2019 at BioCorRx, roughly flat from $4.2 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $4.2 million in Q3 2019 to a low of $685.0 in Q3 2015.
• A 5-year average of $1.3 million and a median of $791966.0 in 2016 frame the typical range for Convertible Debt.
• Across the five-year window, Convertible Debt jumped 73150.51% in 2016 and soared 166.2% in 2018, its largest moves.
• BioCorRx's Convertible Debt stood at $5530.0 in 2015, then soared by 12355.39% to $688783.0 in 2016, then soared by 192.7% to $2.0 million in 2017, then rose by 18.2% to $2.4 million in 2018, then surged by 74.58% to $4.2 million in 2019.
• According to Business Quant data, Convertible Debt over the past three periods registered $4.2 million, $4.2 million, and $2.4 million for Q4 2019, Q3 2019, and Q1 2018 respectively.

Peer Comparison